Synchron Expands Advisory Board as Brain-Computer Interface Device Stentrode™ Advances into Patients in US Clinical Trials NEW YORK, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Synchron, a brain computer interface (BCI) company, today announced the expansion of its advisory board comprised of industry pioneers, to provide...